Introduction: Lipid abnormalities and increase in inflammatory markers are common among patients with End Stage Renal Disease (ESRD) and it tends to persist/worsen even after initiating Intermittent Haemodialysis (IHD). The cardiovascular mortality and morbidity remains significantly high in this population.
Aim: The present study was carried out to assess the pattern of lipid abnormality in our population and to find its association with inflammatory markers.